日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia

3H-吡唑并[4,3-f]喹啉铰链结合剂,一种可用于开发新型抗FLT3驱动白血病激酶抑制剂的可调支架

Dayal, Neetu; Řezníčková, Eva; Hernandez, Delmis E; Peřina, Miroslav; Bělíček, Jakub; Vojáčková, Veronika; Krňávková, Petra; Bařina, Marek; Brauer, Nickolas R; Hunjan, Mandeep Kaur; Yadav, Pratik; Jorda, Radek; Sintim, Herman O

Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors

临床相关激酶抑制剂的非激酶脱靶抑制活性

Brauer, Nickolas R; Kempen, Allison L; Hernandez, Delmis; Sintim, Herman O

Boronic Acid-Containing 3H- pyrazolo[4,3-f]quinoline Compounds as Dual CLK/ROCK Inhibitors with Anticancer Properties

含硼酸的3H-吡唑并[4,3-f]喹啉化合物作为双重CLK/ROCK抑制剂具有抗癌特性

Dayal, Neetu; Chaudhuri, Riddhi; Yeboah, Kofi Simpa; Brauer, Nickolas R; Sintim, Herman O

Discovery of imidazo[1,2-b]pyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myeloma

发现具有优异抗多发性骨髓瘤活性的含咪唑并[1,2-b]哒嗪的TAK1激酶抑制剂

Akwata, Desmond; Kempen, Allison L; Lamptey, Jones; Dayal, Neetu; Brauer, Nickolas R; Sintim, Herman O

Dual FLT3/haspin kinase inhibitor based on 3H-pyrazolo[4,3-f]quinoline scaffold with activities against acute myeloid leukemia

基于3H-吡唑并[4,3-f]喹啉骨架的双重FLT3/haspin激酶抑制剂,具有抗急性髓系白血病活性

Kempen, Allison L; Brauer, Nickolas R; Sintim, Herman O

Development of an extrusion-based 3D-printing strategy for clustering of human neural progenitor cells

基于挤压的 3D 打印策略的开发,用于聚集人类神经祖细胞

Ines Bilkic, Diana Sotelo, Stephanie Anujarerat, Nickolas R Ortiz, Matthew Alonzo, Raven El Khoury, Carla C Loyola, Binata Joddar